These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38443979)

  • 1. Integrative analysis of chromatin accessibility and transcriptome landscapes in the induction of peritoneal fibrosis by high glucose.
    Song Q; Wang P; Wang H; Pan M; Li X; Yao Z; Wang W; Tang G; Zhou S
    J Transl Med; 2024 Mar; 22(1):243. PubMed ID: 38443979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
    Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
    Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
    Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
    Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3/HIF-1α signaling activation mediates peritoneal fibrosis induced by high glucose.
    Yang X; Bao M; Fang Y; Yu X; Ji J; Ding X
    J Transl Med; 2021 Jun; 19(1):283. PubMed ID: 34193173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells.
    Han SM; Ryu HM; Suh J; Lee KJ; Choi SY; Choi S; Kim YL; Huh JY; Ha H
    Sci Rep; 2019 Feb; 9(1):1497. PubMed ID: 30728376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
    Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
    Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
    J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of STAT3 Signaling in High Glucose-Induced Epithelial Mesenchymal Transition in Human Peritoneal Mesothelial Cell Line HMrSV5.
    Zhang P; Dai H; Peng L
    Kidney Blood Press Res; 2019; 44(2):179-187. PubMed ID: 30943519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
    Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
    Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
    Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
    Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition.
    Wang J; Lv X; A-Ni-Wan AS; Tian SS; Wang JM; Liu HY; Fan XG; Zhou SJ; Yu P
    Front Pharmacol; 2023; 14():1152611. PubMed ID: 37251320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-Inducible Factor-1α Activates the Transforming Growth Factor-β/SMAD3 Pathway in Kidney Tubular Epithelial Cells.
    Kushida N; Nomura S; Mimura I; Fujita T; Yamamoto S; Nangaku M; Aburatani H
    Am J Nephrol; 2016; 44(4):276-285. PubMed ID: 27607351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein inhibits HIF-1α and attenuates high glucose-induced peritoneal mesothelial-mesenchymal transition and fibrosis via the mTOR/OGT pathway.
    Wang J; Lv X; Lin Y; Aniwan A; Liu H; Zhou S; Yu P
    Sci Rep; 2024 Oct; 14(1):24369. PubMed ID: 39420031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
    Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
    Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
    Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
    Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.
    Jang YH; Shin HS; Sun Choi H; Ryu ES; Jin Kim M; Ki Min S; Lee JH; Kook Lee H; Kim KH; Kang DH
    Lab Invest; 2013 Feb; 93(2):194-206. PubMed ID: 23207448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
    Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
    Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosis.
    Sun J; Tang L; Shan Y; Yu M; Sheng L; Huang L; Cao H; Dai H; Wang F; Zhao J; Sheng M
    J Ethnopharmacol; 2023 Jun; 309():116343. PubMed ID: 36906159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
    Wilson RB; Archid R; Reymond MA
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.